Evidence map›Paper›PMID 42282905›Full record

ArticleCase reports in medicine2026

Combined Mutations of LTBP3 and COL5A1A in Geleophysic Dysplasia.

Adel Alsharei, Mohammad T Batayneh, Firas Zraiqi, Yazan M Al-Omari, Abdullah M Al-Ali, Almu'atasim Khamees, Saleh A Ba-Shammakh, Aiman Al Sharei, Raed M Al-Zoubi, Mazhar S Al Zoubi

Abstract read
In one paragraph

Article in Case reports in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Adel AlshareiFaculty of Medicine, Yarmouk University, P.O. Box 566, Irbid, 21163, Jordan, yu.edu.jo.
Mohammad T BataynehFaculty of Medicine, Yarmouk University, P.O. Box 566, Irbid, 21163, Jordan, yu.edu.jo.
Firas ZraiqiFaculty of Medicine, Yarmouk University, P.O. Box 566, Irbid, 21163, Jordan, yu.edu.jo.
Yazan M Al-OmariFaculty of Medicine, Yarmouk University, P.O. Box 566, Irbid, 21163, Jordan, yu.edu.jo.
Abdullah M Al-AliFaculty of Medicine, Yarmouk University, P.O. Box 566, Irbid, 21163, Jordan, yu.edu.jo.
Almu'atasim KhameesFaculty of Medicine, Yarmouk University, P.O. Box 566, Irbid, 21163, Jordan, yu.edu.jo.ORCID https://orcid.org/0000-0002-6282-8351
Saleh A Ba-ShammakhPrincess Basma Teaching Hospital, Ministry of Health, P.O. Box 63001, Irbid, 22110, Jordan, moh.gov.jo.ORCID https://orcid.org/0000-0003-1927-8507
Aiman Al ShareiDepartment of Pharmacology, Community Medicine and Clinical Skills, Faculty of Medicine, The Hashemite University, Al Zarqa, Jordan, hu.edu.jo.ORCID https://orcid.org/0000-0001-5323-6103
Raed M Al-ZoubiSurgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha, Qatar, hamad.qa.ORCID https://orcid.org/0000-0002-0548-429X
Mazhar S Al ZoubiDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 21163, Jordan, yu.edu.jo.ORCID https://orcid.org/0000-0003-0248-4777

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Geleophysic dysplasias (GDs) are uncommon genetically predisposed abnormalities that interfere with skeletal growth and formation. Several GD subtypes have different clinical manifestations. The current report presents the case of a 7-year-old Syrian boy with a medical history of repeated bone fractures and noticeable facial characteristics. Initial laboratory examinations revealed normal results, except for low serum phosphate and ferritin levels. The X-ray images showed no abnormalities. The DEXA scan was like that of a 92.1-year-old. Karyotype analysis revealed 46 XY. Genetic testing results showed compound heterozygous mutations in the Latent Transforming Growth Factor Beta Binding Protein 3 (LTBP3) gene and a heterozygous mutation in collagen Type V Alpha 1 (COL5A1), consistent with the patient's clinical manifestations. The following fractures were treated using a combination of nonsurgical casting and surgical intervention. The LTBP3 gene mutations are associated with GD. However, the COL5A1 gene mutations are assumed to be associated with Ehlers-Danlos syndrome Type 1. However, the patient did not exhibit the typical features of joint hypermobility or skin abnormalities, suggesting that the COL5A1 mutation may have a minor effect on his condition. In conclusion, this case highlights the importance of genetic testing in children with repeated fractures and abnormal physical traits. Although the COL5A1 mutation may have a minor influence, further investigation is needed to understand its long-term effects. This instance also emphasizes the range of physical characteristics that can occur with GD and Marfan syndrome, even when caused by the same genetic mutations.

Indexed as

bone fractureCOL5A1geleophysic dysplasiaLTBP3

Identifiers

PMID42282905
PMCPMC13250839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.